SPYRE THERAPEUTICS, INC.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2017 | 33.3M |
| FY2018 | 48.3M |
| FY2019 | 58.2M |
| FY2020 | 106.7M |
| FY2021 | 5.3M |
| FY2022 | 6.7M |
| FY2023 | 6.9M |
| FY2024 | 60.3M |
| FY2025 | 78.2M |
| FY2026 | 78.5M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2017 | 33.3M |
| FY2018 | 48.3M |
| FY2019 | 58.2M |
| FY2020 | 106.7M |
| FY2021 | 5.3M |
| FY2022 | 6.7M |
| FY2023 | 6.9M |
| FY2024 | 60.3M |
| FY2025 | 78.2M |
| FY2026 | 78.5M |